open access

Journal of Genomics and Precision Medicine

Personalized Therapeutics

Personalized therapeutics focuses on designing and selecting treatments based on an individual's unique genetic, molecular, and clinical characteristics. Rather than relying on standardized therapies, this approach tailors medications, dosages, and treatment plans to optimize effectiveness and reduce adverse effects. By integrating genomic profiling, pharmacogenomics, biomarker analysis, and digital health tools, personalized therapeutics offers targeted interventions for conditions such as cancer, autoimmune disorders, infectious diseases, and chronic illnesses. This strategy enables clinicians to match therapies with patient-specific biological pathways, improving treatment responses and long-term outcomes. Personalized therapeutics also supports adaptive treatment planning as new molecular information emerges.

×

Contact Emails

genomics@confmeets.net
support@confmeets.com
finance@confmeets.com
editorial@confmeets.com

Article Processing Timeline

Stage 1 Initial Quality & Plagiarism Check
The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns.
Stage 2 Editorial Assessment & Peer Review
Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy.
Stage 3 Revision & Editorial Decision
Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed.
Stage 4 Production & Publication
Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication.
Processing Time Notice: Processing times vary depending on the nature and complexity of the manuscript, reviewer availability, the extent of revisions required, author response times, and production requirements. The journal does not guarantee a fixed peer-review or publication timeframe.

EDITORIAL & PUBLICATION INFORMATION

English Publication Language
Single-Blind Peer-Review Model
17% Acceptance Rate
<18% Similarity Screening Guideline
Open Access Access Model

All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.

Why Publish with us?

  • Rigorous Peer Review
  • Rapid Publication
  • Global Open Access
  • Crossref DOI
  • International Editorial Board
  • Global Visibility
  • Plagiarism Screening
  • Dedicated Author Support
  • Special Issues
  • Transparent Publication Process
  • High Publishing Standards
  • Worldwide Research Community
  • Journal Flyer

    Flyer Image